Merck has announced that WINREVAIR® (sotatercept) is now authorized for use in Canada in combination with standard pulmonary arterial...

A new investigation, "A Canadian Initiative: Exploring Adult Pulmonary Hypertension," highlights critical issues such as diagnostic...

We are pleased to announce that sotatercept, a new drug for patients diagnosed with pulmonary arterial hypertension (PAH), is now listed...

This article originally appeared in The Hills Times on May 6, 2024 Have you ever tried to fix something without the right tool? If you...

Tune in to the latest episode of the PHaware podcast, where Dr. Jason Weatherald, a pulmonologist at the University of Alberta, delves...

A recent report sheds light on the critical need for British Columbia to bolster its Public Drug Coverage. Over the past five years, BC...

Board member Joan Paulin and PHA Canada Ambassador Jennifer Bryson attended the Rare Disease Summit hosted by the Canadian Organization...

The US Food and Drug Administration (FDA) has granted approval for the medication sotatercept, a significant milestone in the treatment...

On June 22nd, 2023, a significant milestone was achieved as the federal government enacted Bill C-22, officially establishing the Canada...

Tax season is here! Before filing your taxes, determine which benefits you may be eligible for. Check out the article below to learn...

On this International Volunteer Day, I am reminded of the incredible support we receive from our community. From our Board of Directors...

Click here to watch Ella's interview on Winnipeg City News --------- After getting a second lease on life following a successful lung...

Each year, September 30 marks the National Day for Truth and Reconciliation. The day honours survivors of the residential school system,...

Bill C-22, the Canada Disability Benefit Act, has become law, marking a significant milestone for people with disabilities in Canada....

This is a big year, marking 15 years of inspiration with PHA Canada. This week we are honoured to get to celebrate this milestone in...

The Pulmonary Hypertension Association of Canada Welcomes Federal Government Investment to Support Access to Rare Disease Drugs...

There is a rapidly growing end-of-life or death doula movement across Canada. Over the last five years, there has been a significant...

Nova Scotia published an update to their Formulary, click here to read it

We are excited to announce that PEI has joined the list of provinces to have taken action and made Opsumit available through public...

We have now returned from our trip west, unloaded the truck and now trying to relax. That isn’t about to happen with my aging parents and...